Quinnova
Pharmaceuticals, Inc., a specialty pharmaceutical company that
develops and markets novel topical delivery platform-based prescription
drugs, today announced the launch of its NEOSALUSTM
CREAM. NEOSALUS CREAM, the latest addition to Quinnova’s NEOSALUS brand,
is a prescription product with anti-inflammatory properties that can be
used without age or long-term use restrictions for the treatment of a
variety of chronic inflammatory skin conditions like atopic dermatitis,
contact dermatitis, and hand eczema. The non-irritating cream is gentle,
safe, and fragrance- and alcohol-free. Using the Proderm
Technology Delivery System (“Proderm”), NEOSALUS CREAM complements
Quinnova’s NEOSALUS product line.
“I routinely use NEOSALUS in my dermatology office”
“I routinely use NEOSALUS in my dermatology office,” says Firas Hougeir,
M.D. “I appreciate the versatility of the product and being able to
choose between the foam and the cream for my patients. The cosmetic
characteristics of the product have led to better patient compliance and
treatment outcomes. NEOSALUS has been a strong addition to my
armamentarium, allowing me to decrease steroid use in my patients and
increase their tolerance of potentially irritating treatment regimens.”
NEOSALUS repairs, protects, and hydrates the skin. NEOSALUS CREAM
restores dysfunctional skin by replenishing lost physiological lipids,
functions as a protectant to reduce the penetration of irritants, and
improves skin hydration. Patients with chronic inflammatory skin
conditions often experience dry, itchy, and scaly skin, with compromised
skin barrier decreasing protection against irritants and infection.
These disorders are characterized by cycles of exacerbations and
remissions. NEOSALUS’ anti-inflammatory properties help reduce the
frequency and severity of flare-ups, decrease reliance on
corticosteroids, and complement other simultaneous treatments.
The cosmetically elegant, non-comedogenic NEOSALUS CREAM has been
formulated for easier application to smaller surface areas, like the
face, and targeted application on other body areas, while the earlier
launched NEOSALUS FOAM is suited for application to larger body areas.